How to Spot a Fake Peptide COA in 60 Seconds
Learn to identify fraudulent Certificates of Analysis in under a minute. Common red flags, what legitimate COAs look like, and verification steps.
503A vs 503B: What Every Pharmacy Buyer Must Know in 2026
Clear breakdown of 503A traditional compounding vs 503B outsourcing facility regulations and what the 2026 Category 1 changes mean for peptide buyers.
FDA Category 1 vs Category 2 Peptides: The 2026 Update Explained
The FDA's Category 1 vs Category 2 peptide classification determines what compounding pharmacies can prepare. Here's what changed in 2026 and what it means.
HPLC vs LC-MS Testing: Which Purity Test Actually Matters for Peptides?
Understand the difference between HPLC and LC-MS testing methods for peptide purity, when each matters, and what to look for on a COA.
Top 5 Red Flags When Evaluating Peptide Suppliers
Five warning signs that indicate a peptide supplier may not be trustworthy. Protect your supply chain with this evaluation framework.
Importing Peptide APIs to the US: Compliance Checklist
Complete compliance checklist for importing peptide APIs into the United States. FDA requirements, customs documentation, and common pitfalls.
Chinese Peptide Manufacturers: A Buyer's Evaluation Guide
How to evaluate Chinese peptide API manufacturers for quality, compliance, and reliability. Due diligence framework for international buyers.
What 'GMP-Certified' Actually Means for Peptides (And What It Doesn't)
Not all GMP claims are equal. Learn what GMP certification actually means in peptide manufacturing and how to verify supplier claims.
Semaglutide API Sourcing: Quality, Cost, and Compliance in 2026
Guide to sourcing semaglutide API for compounding pharmacies and clinics. Quality benchmarks, cost ranges, and regulatory compliance requirements.
Peptide Price Benchmarks 2026: What B2B Buyers Should Expect
Current market pricing benchmarks for popular peptide APIs in 2026. What to expect, what's too cheap, and how to evaluate value vs. cost.
BPC-157 Sourcing After the Category 2 Reversal: What Buyers Need to Know
BPC-157 is back to Category 1 in 2026. What compounding pharmacies and clinics need to know about sourcing quality BPC-157 API.
Korea as a Peptide Sourcing Hub: Quality Meets Competitive Pricing
Why South Korea is emerging as a strategic peptide API sourcing hub. MFDS regulatory standards, key manufacturers, and procurement advantages.
Compounding Pharmacy Peptide Procurement: A Step-by-Step Workflow
Complete procurement workflow for compounding pharmacies sourcing peptide APIs.
How Telehealth Platforms Source Peptides at Scale
Sourcing strategy for telehealth platforms needing high-volume peptide fulfillment.
Peptide Stability & Storage: What Buyers Need to Know
Essential guide to peptide API storage, stability testing, and beyond-use dating.
The Rise of Peptide Clinics: Sourcing for the Longevity Market
How longevity clinics are building peptide programs and sourcing strategies.
Understanding Endotoxin Testing in Peptide Quality Control
Why endotoxin testing is critical for injectable peptides and what to look for on COAs.
Indonesia Peptide Market: Regulatory Landscape & Opportunity
Overview of the Indonesian peptide market including BPOM registration and market entry.
Peptide Supply Chain Risk Management for Pharmacies
Framework for identifying and mitigating supply chain risks in peptide procurement.